European Journal of Cancer
Volume 41, Issue 11 , Pages 1528-1532, July 2005

Assessment of the value of confirming responses in clinical trials in oncology

  • Jose Luis Perez-Gracia

      Affiliations

    • Medical Oncology Department, Clínica Universitaria de Navarra, Avenida de Pío XII 36, 31008 Pamplona, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 658 92 02 12; fax: +34 948 255 500.
    • ,
  • Maria Muñoz

      Affiliations

    • Clinical Research Department, Eli Lilly and Company, Madrid, Spain
    • ,
  • Grant Williams

      Affiliations

    • US Food and Drug Administration, USA
    • ,
  • Jun Wu

      Affiliations

    • Clinical Research Department, Eli Lilly and Company Indianapolis, USA
    • ,
  • Eva Carrasco

      Affiliations

    • Clinical Research Department, Eli Lilly and Company, Madrid, Spain
    • ,
  • Ignacio Garcia-Ribas

      Affiliations

    • Clinical Research Department, Eli Lilly and Company, Madrid, Spain
    • ,
  • Ana Peiro

      Affiliations

    • Clinical Research Department, Eli Lilly and Company, Madrid, Spain
    • ,
  • Jose Maria Lopez-Picazo

      Affiliations

    • Medical Oncology Department, Clínica Universitaria de Navarra, Avenida de Pío XII 36, 31008 Pamplona, Spain
    • ,
  • Alfonso Gurpide

      Affiliations

    • Medical Oncology Department, Clínica Universitaria de Navarra, Avenida de Pío XII 36, 31008 Pamplona, Spain
    • ,
  • Ana Chopitea

      Affiliations

    • Medical Oncology Department, Clínica Universitaria de Navarra, Avenida de Pío XII 36, 31008 Pamplona, Spain
    • ,
  • Salvador Martín-Algarra

      Affiliations

    • Medical Oncology Department, Clínica Universitaria de Navarra, Avenida de Pío XII 36, 31008 Pamplona, Spain
    • ,
  • Jesus García-Foncillas

      Affiliations

    • Medical Oncology Department, Clínica Universitaria de Navarra, Avenida de Pío XII 36, 31008 Pamplona, Spain
    • ,
  • Johannes Blatter

      Affiliations

    • Clinical Research Department, Eli Lilly and Company, Frankfort, Germany

Received 6 December 2004; received in revised form 20 January 2005; accepted 27 January 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(05)00210-8

doi:10.1016/j.ejca.2005.01.023

European Journal of Cancer
Volume 41, Issue 11 , Pages 1528-1532, July 2005

Article Tools